切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - PARP - Flk1 - adrenergic receptor

18件产品中的 1-10

页面
每页
清除全部
  1. Rucaparib (free base)
    A8893 Rucaparib (free base)
    中文名: 瑞卡帕布
    Target: PARP
    Summary: PARP抑制剂
      ≥16.15 mg/mL
      insoluble in H2O
  2. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  3. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  4. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  5. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP抑制剂
      ≥71.43 mg/mL
      insoluble in H2O
  6. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  7. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  9. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    中文名: 维利帕尼二盐酸盐
    Target: PARP
    Summary: PARP-1/PARP-2抑制剂
      ≥31.7 mg/mL
      ≥104 mg/mL
  10. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O

18件产品中的 1-10

页面
每页